Urol. praxi. 2020;21(1):34-37 | DOI: 10.36290/uro.2020.018

Differential diagnosis of proteinuria

MUDr. Nadežda Petejová, Ph.D., MSc.1,2,3, doc. MUDr. Arnošt Martínek, CSc.1,2, prof. MUDr. Josef Zadražil, CSc.3
1 Interní klinika Fakultní nemocnice, Ostrava
2 Lékařská fakulta Ostravské Univerzity, Ostrava
3 III. interní klinika nefrologická, revmatologická a endokrinologická, Fakultní nemocnice Olomouc a LF UP Olomouc

The paper briefly describes and summarizes the current clinical knowledge and complex recommendations for differential diagnosis of proteinuria.

Keywords: proteinuria, glomerulonephritis, nephrotic syndrome.

Published: April 17, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Petejová N, Martínek A, Zadražil J. Differential diagnosis of proteinuria. Urol. praxi. 2020;21(1):34-37. doi: 10.36290/uro.2020.018.
Download citation

References

  1. Bazari H. Hematuria and Proteinuria. In: Singh AK, Loscalzo J. The Brigham Intenxive Review of Internal Medicine. 2nd Edition. Oxford University Press. New York, USA, 2014: 615-625. Go to original source...
  2. Tesař V. Vyšetřovací metody u nemocí ledvin. Klinická nefrologie. 2. zcela přepracované a doplněné vydání. Grada, Praha 2015: 53-70.
  3. Nielsen R, Christensen EI, Birn H. Megalin and cubilin in proximal tubule protein reabsorption: from experimental models to human disease. Kidney Int. 2016; 89(1): 58-67. Go to original source... Go to PubMed...
  4. Comper WD, Russo LM, Vuchkova J. Are filtered plasma proteins processed in the same way by the kidney? J. Theor. Biol. 2016; 410: 18-24. Go to original source... Go to PubMed...
  5. Sun J, Hultenby K, Axelsson J, et al. Proximal Tubular Expression Patterns of Megalin and Cubilin in Proteinuric Nephropathies. Kidney Int. Rep. 2017; 2(4): 721-732. Go to original source... Go to PubMed...
  6. Rovin BH. Assessment of urinary protein excretion and evaluation of isolated non-nephrotic proteinuria in adults. UpToDate [online]. 2019; [cit. 29-09-2019]. Dostupné z: www.uptodate.com.
  7. Svobodová R. Systémová onemocnění pojiva a jejich komplikace. Internî Med. 2012; 14(11): 443-446.
  8. Vivino FB. Sjogren's syndrome: Clinical aspects. Clin. Immunol. 2017; 182: 48-54. Go to original source... Go to PubMed...
  9. Hughes M, Herrick AL. Systemic sclerosis. Br. J. Hosp. Med (Lond). 2019; 80(9): 530-536. Go to original source... Go to PubMed...
  10. Wasserman AM. Diagnosis and management of rheumatoid arthritis. Am. Fam. Physician. 2011; 84(11): 1245-1252. Go to PubMed...
  11. Findlay AR, Goyal NA, Mozaffar T. An overview of polymyositis and dermatomyositis. Muscle Nerve. 2015; 51(5): 638-656. Go to original source... Go to PubMed...
  12. Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. Lancet 2016; 387(10038): 2641-2654. Go to original source... Go to PubMed...
  13. Yates M, Watts R. ANCA-associated vasculitis. Clin. Med. (Lond). 2017; 17(1): 60-64. Go to original source... Go to PubMed...
  14. Couser WG. Primary Membranous Nephropathy. Clin. J. Am. Soc. Nephrol. 2017; 12(6): 983-997. Go to original source... Go to PubMed...
  15. Karkar A, Abdelrahman M. Protein-to-creatinine ratio: a valid estimate and alternative to 24 hour proteinuria. Saudi J. Kidney Dis. Transpl. 2010; 21(5): 949-950. Go to PubMed...
  16. Šálek T. Odhadovaná glomerulární filtrace u dospělých pacientů. Klin. Farmakol. Farm 2015; 29(4): 153-155.
  17. Lukešová Š. Imunologie, autoimunitní onemocnění. Med. Praxi. 2016; 13(4): 171-174. Go to original source...
  18. Rennke HG. Kidney pathology part one and two. Intensive Review of Nephrology. Brigham and Woman's Hospital, Harvard Medical School, Postgdraduate Medical Education, USA. 2019. Sborník přednášek: 110-218.
  19. Singh AK. Approach to Proteinuria and Hematuria. 41. Annual Intensive Review of Internal Medicine. Brigham and Woman's Hospital, Harvard Medical School, Postgdraduate Medical Education, USA. 2018. Sborník přednášek: 121-135.
  20. Vivarelli M, Massella L, Ruggiero B, et al. Minimal Change Disease. Clin. J. Am. Soc. Nephrol. 2017; 12(2): 332-345. Go to original source... Go to PubMed...
  21. D'Agati VD, Kaskel FJ, Falk RJ. Focal segmental glomerulosclerosis. N. Engl. J. Med. 2011; 365(25): 2398-2411. Go to original source... Go to PubMed...
  22. Cossey NL, Larsen CP, Liapis H. Collapsing glomerulopathy: a 30-year perspective and single, large center experience. Clin. Kidney J. 2017; 10(4): 443-449. Go to original source... Go to PubMed...
  23. Cavallasca JA, Costa CA, Musuruana JL, et al. Proliferative Diffuse Glomerulonephritis in Rheumatoid Arthritis. J. Clin. Rheumatol. 2018; 24(2): 103-104. Go to original source... Go to PubMed...
  24. Takehara E, Mandai S, Shikuma S, et al. Post-infectious Proliferative Glomerulonephritis with Monoclonal Immunoglobulin G Deposits Associated with Complement Factor H Mutation. Intern. Med. 2017; 56(7): 811-817. Go to original source... Go to PubMed...
  25. Sethi S, Fervenza FC. Standardized classification and reporting of glomerulonephritis. Nephrol. Dial. Transplant. 2019; 34(2): 193-199. Go to original source... Go to PubMed...
  26. Floege J, Amann K. Primary glomerulonephritides. Lancet 2016; 387(10032): 2036-2048. Go to original source... Go to PubMed...
  27. Rodrigues JC, Haas M, Reich HN. IgA Nephropathy. Clin. J. Am. Soc. Nephrol. 2017; 12(4): 677-686. Go to original source... Go to PubMed...
  28. Almaani S, Meara A, Rovin BH. Update on Lupus Nephritis. Clin. J. Am. Soc. Nephrol. 2017; 12(5): 825-835. Go to original source... Go to PubMed...
  29. Kruegel J, Rubel D, Gross O. Alport syndrome-insights from basic and clinical research. Nat. Rev. Nephrol. 2013; 9(3): 170-178. Go to original source... Go to PubMed...
  30. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney inter., Suppl. 2012; 2: 139-274.




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.